secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0001193125-23-102020
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Kush Parmar resigns from Vor Biopharma board before 2023 annual meeting
--------------------------------------------------------------------------------

- Kush Parmar, M.D., Ph.D., resigned effective immediately prior to the 2023 Annual Meeting.
- Parmar was one of the longest-tenured directors, joining the Board in February 2019.
- He previously served as Board chair (Jan-Jun 2021) and interim CEO (Feb-Aug 2019).
- The resignation was not due to any disagreement with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312523102020/0001193125-23-102020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312523102020/d493240d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-102020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer